Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 0 | 0 | 0 | 0 | 7,666 |
| Cost of Goods | N/A | N/A | N/A | N/A | 6,857 |
| Gross Profit | N/A | N/A | N/A | N/A | 809 |
| Operating Expenses | 0 | 0 | 0 | 0 | 15,005 |
| Operating Income | N/A | N/A | N/A | N/A | -13,339 |
| Interest Expense | 0 | 0 | 0 | 0 | 2,481 |
| Other Income | 0 | 0 | 0 | 0 | 8,700 |
| Pre-tax Income | 0 | 0 | 0 | 0 | -7,120 |
| Net Income Continuous | N/A | N/A | N/A | N/A | -7,120 |
| Net Income | $N/A | $N/A | $N/A | $N/A | $-7,120 |
| EPS Basic Total Ops | N/A | N/A | N/A | N/A | -74.00 |
| EPS Basic Continuous Ops | N/A | N/A | N/A | N/A | -71.30 |
| EPS Diluted Total Ops | N/A | N/A | N/A | N/A | -74.00 |
| EPS Diluted Continuous Ops | N/A | N/A | N/A | N/A | -71.30 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | 36.00 | 5.87 | N/A |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $-11,331 |